Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonathan E Alpert

Showing results (31-40 of 136) with videos related to

Pageof 14
Sort By:
International Clinical Psychopharmacology|February 25, 2005
The relationship between early changes in the HAMD-17 anxiety/somatization factor items and treatment outcome among depressed outpatientsAmy Farabaugh, David Mischoulon, Maurizio Fava, et al.
Psychiatry Research|May 26, 2004
Anxiety and somatic symptoms as predictors of treatment-related adverse events in major depressive disorderGeorge I Papakostas, Timothy Petersen, Megan E Hughes, et al.
Annals of Clinical Psychiatry : Official Journal of the American Academy of Clinical Psychiatrists|June 6, 2002
Folinic acid (Leucovorin) as an adjunctive treatment for SSRI-refractory depressionJonathan E Alpert, David Mischoulon, Grace E F Rubenstein, et al.
Psychiatry Research|December 13, 2006
Timing of clinical improvement and symptom resolution in the treatment of major depressive disorderGeorge I Papakostas, Timothy Petersen, Katherine G Sklarsky, et al.
Psychiatry Research|February 19, 2002
NEO-FFI factor scores as predictors of clinical response to fluoxetine in depressed outpatientsTimothy Petersen, George I Papakostas, Kathryn Bottonari, et al.
The American Journal of Psychiatry|November 26, 2003
The impact of medical comorbidity on acute treatment in major depressive disorderDan V Iosifescu, Andrew A Nierenberg, Jonathan E Alpert, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|July 4, 2009
Frontal EEG predictors of treatment outcome in major depressive disorderDan V Iosifescu, Scott Greenwald, Philip Devlin, et al.
CNS Spectrums|October 3, 2014
Reliability and validity of the Symptoms of Depression Questionnaire (SDQ)Paola Pedrelli, Mark A Blais, Jonathan E Alpert, et al.
The Journal of Nervous and Mental Disease|September 9, 2015
The Role of Anger/Hostility in Treatment-Resistant Depression: A Secondary Analysis From the ADAPT-A StudyLauren B Fisher, Maurizio Fava, Gheorghe D Doros, et al.
Annals of Clinical Psychiatry : Official Journal of the American Academy of Clinical Psychiatrists|April 25, 2007
Hopelessness as a predictor of non-response to fluoxetine in major depressive disorderGeorge I Papakostas, Timothy Petersen, Caitlin H Homberger, et al.
Pageof 14

Showing results (31-40 of 136) with videos related to

Sort By:
Pageof 14
International Clinical Psychopharmacology|February 25, 2005
The relationship between early changes in the HAMD-17 anxiety/somatization factor items and treatment outcome among depressed outpatientsAmy Farabaugh, David Mischoulon, Maurizio Fava, et al.
Psychiatry Research|May 26, 2004
Anxiety and somatic symptoms as predictors of treatment-related adverse events in major depressive disorderGeorge I Papakostas, Timothy Petersen, Megan E Hughes, et al.
Annals of Clinical Psychiatry : Official Journal of the American Academy of Clinical Psychiatrists|June 6, 2002
Folinic acid (Leucovorin) as an adjunctive treatment for SSRI-refractory depressionJonathan E Alpert, David Mischoulon, Grace E F Rubenstein, et al.
Psychiatry Research|December 13, 2006
Timing of clinical improvement and symptom resolution in the treatment of major depressive disorderGeorge I Papakostas, Timothy Petersen, Katherine G Sklarsky, et al.
Psychiatry Research|February 19, 2002
NEO-FFI factor scores as predictors of clinical response to fluoxetine in depressed outpatientsTimothy Petersen, George I Papakostas, Kathryn Bottonari, et al.
The American Journal of Psychiatry|November 26, 2003
The impact of medical comorbidity on acute treatment in major depressive disorderDan V Iosifescu, Andrew A Nierenberg, Jonathan E Alpert, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|July 4, 2009
Frontal EEG predictors of treatment outcome in major depressive disorderDan V Iosifescu, Scott Greenwald, Philip Devlin, et al.
CNS Spectrums|October 3, 2014
Reliability and validity of the Symptoms of Depression Questionnaire (SDQ)Paola Pedrelli, Mark A Blais, Jonathan E Alpert, et al.
The Journal of Nervous and Mental Disease|September 9, 2015
The Role of Anger/Hostility in Treatment-Resistant Depression: A Secondary Analysis From the ADAPT-A StudyLauren B Fisher, Maurizio Fava, Gheorghe D Doros, et al.
Annals of Clinical Psychiatry : Official Journal of the American Academy of Clinical Psychiatrists|April 25, 2007
Hopelessness as a predictor of non-response to fluoxetine in major depressive disorderGeorge I Papakostas, Timothy Petersen, Caitlin H Homberger, et al.
Pageof 14